Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Co-Diagnostics Inc (NASDAQ: CODX) closed the day trading at $0.35 up 2.65% from the previous closing price of $0.34. In other words, the price has increased by $2.65 from its previous closing price. On the day, 1.25 million shares were traded. CODX stock price reached its highest trading level at $0.363 during the session, while it also had its lowest trading level at $0.3241.
Ratios:
For a better understanding of CODX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.83 and its Current Ratio is at 4.12. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
On December 29, 2021, Sidoti started tracking the stock assigning a Buy rating and target price of $14.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CODX now has a Market Capitalization of 18453052 and an Enterprise Value of 1943573. For the stock, the TTM Price-to-Sale (P/S) ratio is 29.82 while its Price-to-Book (P/B) ratio in mrq is 0.31. Its current Enterprise Value per Revenue stands at 1.936 whereas that against EBITDA is -0.052.
Stock Price History:
The Beta on a monthly basis for CODX is 0.94, which has changed by -0.71333337 over the last 52 weeks, in comparison to a change of 0.17342639 over the same period for the S&P500. Over the past 52 weeks, CODX has reached a high of $1.40, while it has fallen to a 52-week low of $0.23. The 50-Day Moving Average of the stock is 9.65%, while the 200-Day Moving Average is calculated to be -19.37%.
Shares Statistics:
Over the past 3-months, CODX traded about 6.59M shares per day on average, while over the past 10 days, CODX traded about 3974300 shares per day. A total of 48.14M shares are outstanding, with a floating share count of 43.08M. Insiders hold about 10.53% of the company’s shares, while institutions hold 10.77% stake in the company. Shares short for CODX as of 1757894400 were 795088 with a Short Ratio of 0.12, compared to 1755216000 on 511469. Therefore, it implies a Short% of Shares Outstanding of 795088 and a Short% of Float of 2.22.
Earnings Estimates
. The current assessment of Co-Diagnostics Inc (CODX) involves the perspectives of 2.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.09 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.72 and -$0.72 for the fiscal current year, implying an average EPS of -$0.72. EPS for the following year is -$0.28, with 2.0 analysts recommending between -$0.17 and -$0.39.
Revenue Estimates
A total of 2 analysts have provided revenue estimates for CODX’s current fiscal year. The highest revenue estimate was $813k, while the lowest revenue estimate was $213k, resulting in an average revenue estimate of $513k. In the same quarter a year ago, actual revenue was $3.92M
